TD Cowen Downgrades Passage Bio to Hold

Benzinga Newsdesk www.benzinga.com Negative 79.5%

Neg 79.5% Neu 0% Pos 0%

TD Cowen analyst Brendan Smith downgrades Passage Bio (NASDAQ:PASG) from Buy to Hold.

Comments

No comments yet. Be the first!